(Q47872903)

6 February 2018

title

Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity (English)

1 reference

6 February 2018

1 reference

1 reference

Petrides AS

1

1 reference

6 February 2018

Stanley T

2

1 reference

6 February 2018

Matthews DE

3

1 reference

6 February 2018

Vogt C

4

1 reference

6 February 2018

Bush AJ

5

1 reference

6 February 2018

Lambeth H

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

published in

Hepatology

1 reference

6 February 2018

volume

28

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

141-149

1 reference

6 February 2018

Pathogenesis of NIDDM. A balanced overview

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Does leptin contribute to diabetes caused by obesity?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Glucose metabolism in perfused skeletal muscle. Pyruvate dehydrogenase activity in starvation, diabetes and exercise

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

In-vivo Measurement of Glucose and Alanine Metabolism with Stable Isotopic Tracers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Issues in biomedical statistics: comparing means by computer-intensive tests

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Hepatic Removal of Insulin in Normal Man: Dose Response to Endogenous Insulin Secretion*

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Impaired glucose tolerance and growth hormone in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

The effect of growth hormone on glucose metabolism and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Hyperglucagonemia and insulin-mediated glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Glucose, Insulin and Somatostatin Infusion for the Determination of Insulin Resistance in Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

The Effect of Somatostatin on Glucose Uptake and Production by Rat Tissues in Vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Potential indications for octreotide in endocrinology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280119

7 January 2021

Identifiers

DOI

10.1002/HEP.510280119

1 reference

6 February 2018

1 reference

6 February 2018